Perfromance Wealth Partners’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.31M Buy
11,191
+22
+0.2% +$6.54K 0.1% 43
2025
Q4
$3.05M Sell
11,169
-60
-0.5% -$16.3K 0.08% 42
2025
Q3
$3.03M Hold
11,229
0.08% 37
2025
Q2
$3.09M Sell
11,229
-100
-0.9% -$27.2K 0.1% 36
2025
Q1
$3.01M Buy
11,329
+57
+0.5% +$14.1K 0.11% 32
2024
Q4
$2.62M Hold
11,272
0.08% 40
2024
Q3
$2.49M Sell
11,272
-501
-4% -$104K 0.09% 38
2024
Q2
$2.31M Hold
11,773
0.09% 36
2024
Q1
$2.53M Hold
11,773
0.11% 45
2023
Q4
$2.48M Hold
11,773
0.11% 51
2023
Q3
$2.36M Hold
11,773
0.11% 55
2023
Q2
$2.16M Hold
11,773
0.1% 61
2023
Q1
$2.25M Hold
11,773
0.12% 57
2022
Q4
$1.98M Sell
11,773
-8
-0.1% -$1.39K 0.12% 52
2022
Q3
$2.09M Hold
11,781
0.12% 45
2022
Q2
$2.41M Hold
11,781
0.14% 44
2022
Q1
$2.8M Hold
11,781
0.12% 48
2021
Q4
$2.69M Buy
+11,781
New +$2.59M 0.11% 54

Other funds holding CME

Perfromance Wealth Partners's CME Position: Q1 2026 in Review

Perfromance Wealth Partners increased its CME Group (CME) stake by 0.2% in Q1 2026, buying an estimated $6.54K and bringing the position to 11,191 shares worth $3.31M. The position accounts for 0.1% of the portfolio, ranked #43.

Perfromance Wealth Partners first reported a position in CME in Q4 2021 and has held it in 18 quarters since. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Perfromance Wealth Partners held 11,191 shares of CME Group worth $3.31M as of Q1 2026.
  • Perfromance Wealth Partners bought 22 CME Group shares in Q1 2026, an estimated $6.54K.
  • CME Group made up 0.1% of Perfromance Wealth Partners's portfolio in Q1 2026, its #43 holding.
  • Perfromance Wealth Partners first reported a position in CME Group in Q4 2021 and has held it in 18 quarters since.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Perfromance Wealth Partners's 13F filing for Q1 2026, filed 10 Apr 2026.